A BST RA CT The oxidation and turnover of plasma glycerol has been studied in lean and obese, fed and starving man by means of a long-term infusion of glycerol-"4C, and the participation of glycerol in gluconeogenesis has been determined.
INTRODUCTION
Until recently, glycerol has been generally regarded as a docking site for the metabolically active free fatty acids (FFA) in adipose tissue. Its presence in the blood or in incubation media has usually been considered as a measure of triglyceride hydrolysis (1) (2) (3) . Relatively scant attention has been paid to the possible oxidative and synthetic fates of glycerol, particularly in man. The role of glycerol in energy metabolism has not been well clarified, especially as compared to the Received for publication 20 December 1971 and in revised form 30 January 1972. participation of fatty acid. Further, although glycerol has been shown to be an active precursor for glucose in vivo and in vitro (4) (5) (6) (7) (8) , its participation in human gluconeogenesis has not been quantitated. This role may become important during periods of caloric deprivation. Therefore, to investigate both the participation of glycerol in oxidative metabolism and its role as a precursor for blood glucose, a series of experiments utilizing long-term constant infusion of glycerol-4C into lean and obese individuals in the fed and fasting states was carried out. METHODS Subjects. 9 lean and 13 obese subjects participated in this study. The ponderal index height in inches 4weight in pounds of the lean subjects varied from 13.9 to 12.6, average 13.3, while the obese subjects ranged from 11.8 to 9.71, average 11.1. Two lean and four obese subjects were studied twice.
Some of the lean subjects were living in our Metabolic Ward as were all of the obese subjects. All subjects were on a regular diet before the start of a fasting period which varied from 6 hr to 7 days for the lean subjects and up to 35 days for the obese subjects. Fasting was used to obtain a wide range of plasma FFA and glycerol levels. Procedure. The subject was at rest in a ventilated room during the course of the experiment. Indwelling catheters were placed in the antecubital vein, through which radioactive glycerol was infused, and in the femoral artery, which was used for taking blood samples. The glycerol-'4C (uniformly labeled) (29.6 mCi/mmole) was prepared for human use by the New England Nuclear Corp. (Boston, Mass.). The labeled glycerol was washed quantitatively from the vial and brought to volume with isotonic saline. At time zero a priming dose was given so that the ratio of priming dose: infusion rate was approximately 150: 1. The priming dose and infusion (maintained at a constant rate for 7-8 hr using a calibrated Harvard infusion pump, Harvard Apparatus Co., Inc., Millis, Mass.) were adjusted so that the total amount of radioactive tracer administered would not exceed 100 ACi in the lean and 200 ptCi in the obese.
Expired air was collected under a plastic hood through which a high airflow was circulated. At timed intervals, the diluted expired air was drawn into Douglas bags by another pump. The 02 and C02 content was measured by means of a calibrated Noyons diaferometer (9) . Expired air and arterial blood samples were collected every 60 min during the first 3 hr and every 30 min thereafter.
Measurements. The specific activity (SA) of 14CO2 was measured according to the method of Fredrickson and Ono (10) as described by us previously (11) .
Other workers have remarked on the contamination of plasma glycerol-"C activity by glucose-1'C activity (8) . In recognition of this the following separation and measurement technique was evolved. A protein-free filtrate was prepared from each sample and placed on an Amberlite IRA-410 resin (Rohm & Haas Co., Philadelphia, Pa.) column as previously described (12) . The eluate contained all of the glycerol and glucose, whereas lactate and other anionic compounds were retained on the column. A 2.0 ml portion of the eluate was placed in a vial containing 15.0 ml of the solution described by Bray (13) and counted. The radioactivity thus determined was primarily from glycerol and glucose, although, as discussed below, some also occurred in other compounds as yet unidentified. The remainder of the column eluate was incubated with Glucostat (Worthington Biochemical Corp., Freehold, N. J.) for 1 hr to convert glucose to gluconic acid. Then a mixture consisting of zeolite, Lloyd's reagent, CuSo4, and Ca(OH)2, prepared as in reference 14, was added and the sample shaken for 30 min to remove the gluconic acid. After centrifugation a portion of the supernate was added to Bray's solutionr for counting. Glycerol content was determined from another sample of the same supernate by an automated technique as modified from Kessler and Lederer (14) (Fig. 1) . The reagents used were identical in concentration to those used in the aforementioned method (14) . Additionally, an appropriate amount of unlabeled glycerol was added to the final eluate and the glycerol was isolated as the tribenzoate derivative by the method of Winkler, Steele, Bjerknes, Rathgreb, nad Altszuler (15) and repeatedly recrystallized until a constant SA was maintained. By this method, it was found that about 50% of the supernatant radioactivity was not from glycerol. The radioactivity of the column eluate and the supernate from the zeolite soda lime treatment were both corrected for this contaminant activity before the SA of glucose and glycerol were calculated.
The validity of this separation procedure was substantiated by means of standard solutions containing appropriate mixtures of '4C-labeled glycerol and glucose at concentrations usually encountered in plasma. Total glycerol was consistently recovered, contaminated by 2% glucose or less.
The levels of glucose and FFA in plasma and of nitrogen in urine were determined as reported previously (12) .
Calculations. The turnover rate of the glycerol was calculated from the infusion rate of the tracer and the SA of the plasma glycerol.
Computation of the rate of oxidation of glycerol presents certain difficulties. The SA of the exhaled C02 rises in the form of an exponential curve approaching an asymptotic value. This rise is due to a slow exchange between the labeled CO2 and the unlabeled bicarbonate pool. The asymptotic value represents the ideal situation in which the exhaled C02 and the body bicarbonate have the same SA as the C02 arising from the tissue oxidation. Issekutz (21) . The other role of glycerol, namely, as a substrate for synthetic reactions is undoubtedly of greater significance to the organism. As cited above, both in vitro and in vivo work has emphasized how efficient is glycerol as a precursor of glucose. FFA cannot serve as a net precursor for glucose. The two organs which are the predominant gluconeogenic sites, liver and kidney, are also the sites of the greatest glycerokinase activity. Particularly during starvation is this role of glycerol manifest. In prolonged fasting, up to 100% of the glycerol turnover is diverted to glucose formation. In other experiments to be reported separately,' the evolution of "GCO during glycerol infusion to fed subjects 'Paul, P., W. M. Bortz, A. C. Haff, and W. L. Holmes.
Evaluation of oxidative metabolism in lean and obese humans by the appearance of 'CO2 during constant rate infusion of palmitate-l-"C, n-glucose-"C(UL), and glycerol-"C(UL). Submitted for publication. was found to be similar to that after infusion of H"COa, indicating rapid oxidation, presumably directly through the tricarboxylic acid cycle, and mixing with body bicarbonate pools. In starvation, however, the "CO2 evolution curve shifted until it was identical with that seen after an infusion of glucose-"C, indicating that nearly all of the glycerol was being utilized for gluconeogenesis.
In Tables III and IV are presented data which enabled us to calculate the relative contributions of protein and glycerol precursors to glucose. Glucose turnover and oxidation data are given from previous experiments (12) in which glucose-"C was similarly infused as described here. These data have been published in detail previously, and are presented here to provide a direct measurement of glucose use and, further, as a comparison for the indirect calculations for glucose use that can be made from these glycerol experiments.
In fasting lean subjects, glucose turnover averaged 402 mmoles/min or 104.2 g/day, of which 70.6 g were oxidized directly as determined from the glucose-"C studies. The present experiments indicated that 251 mmoles/min or 65.4 g of glucose were oxidized, in good agreement with the value estimated directly. The figure is derived from measurement of CO and glu- (Table III) . For the fasting obese subjects (Table IV) glucose turnover was 442.8 mmoles/min or 114.8 g/day of which 51.8 g was oxidized. Glucose oxidation as estimated from the glycerol experiments was 49.0 g/day. This is determined using the observation that with fasting in the obese, glycerol is quantitatively converted to glucose (Table II) (24) . In other words, the obese subject is primed for starvation. Observations from these experiments are consistent with this hypothesis. After short fasting the obese group has higher blood glycerol levels and higher glycerol turnover than the lean. Further, in the obese, glycerol contributes relatively more to glucose formation, even after short fasting. In the fasting state (Table II) , it can be seen that glycerol is quantitatively more important than protein as a source for new glucose. Utilizing the data in Tables I and II one calculates that with fasting in the obese subjects, glycerol represented 79.3% of the total (glycerol and protein) gluconeogenic substrates. In the comparable lean group, glycerol accounts for only 38% of the same total. Conversely, the obese rely less on protein catabolism as a source of glucose carbon. The ability of fat individuals to spare protein breakdown during acute starvation has previously been noted (25) . The increased availability of glycerol to supply glucose is though to be at least partially responsible for this.
